Cargando…
Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
BACKGROUND & AIMS: Bulevirtide (BLV) is a small lipopeptide agent that specifically binds to the sodium taurocholate cotransporting polypeptide (NTCP) bile salt transporter and HBV/HDV receptor on the surface of human hepatocytes and inhibits HDV and HBV entry. As a satellite virus of HBV, HDV v...
Autores principales: | Mateo, Roberto, Xu, Simin, Shornikov, Alex, Yazdi, Tahmineh, Liu, Yang, May, Lindsey, Han, Bin, Han, Dong, Martin, Ross, Manhas, Savrina, Richards, Christopher, Marceau, Caleb, Aeschbacher, Thomas, Chang, Silvia, Manuilov, Dmitry, Hollnberger, Julius, Urban, Stephan, Asselah, Tarik, Abdurakhmanov, Dzhamal, Lampertico, Pietro, Maiorova, Evguenia, Mo, Hongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622701/ https://www.ncbi.nlm.nih.gov/pubmed/37929228 http://dx.doi.org/10.1016/j.jhepr.2023.100893 |
Ejemplares similares
-
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
por: Costante, Federico, et al.
Publicado: (2023) -
HBV and HDV: New Treatments on the Horizon
por: Zuccaro, Valentina, et al.
Publicado: (2021) -
Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014) -
Hepatitis Delta Virus: HDV-HBV Interactions
por: Sureau, Camille
Publicado: (2006) -
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression
por: Jachs, Mathias, et al.
Publicado: (2023)